Clinical Study on the Prevention of Oxaliplatin-Induced Neurotoxicity with Guilongtongluofang: Results of a Randomized, Double-Blind, Placebo-Controlled Trial

Table 4

Adverse events in the trial group and the control group.

Adverse events	Trial group (𝑛, %); (𝑛=60)	Control group (𝑛, %); (𝑛=60)	𝑃 value
Anemia
Grades 1-2	7 (11.7)	8 (13.3)	0.78
Grades 3-4	0	0
Neutropenia
Grades 1-2	14 (23.3)	13 (21.7)	0.92
Grades 3-4	7 (11.7)	6 (10.0)
Thrombocytopenia
Grades 1-2	10 (16.7)	9 (15.0)	0.80
Grades 3-4	0	0
Nausea
Grades 1-2	18 (30.0)	20 (33.3)	0.69
Grades 3-4	0	0
Vomiting
Grades 1-2	14 (23.3)	16 (26.7)	0.67
Grades 3-4	0	0
Diarrhea
Grades 1-2	12 (20.0)	13 (21.7)	0.56
Grades 3-4	1 (1.7)	3 (5.0)
Stomatitis
Grades 1-2	12 (20.0)	11 (18.3)	0.81
Grades 3-4	0	0